NG2-73 - A Novel Agent For The Treatment of Insomnia, No Country

 
Key Data:
Drug (brand/generic)
NG2-73
Company/Licensee
Neurogen
Therapy Class
GABA partial agonist
Product Description
A selective, partial GABA alpha-3 agonist
Current Indication
Treatment of insomnia
Market Sector
CNS
Development Status
Phase II

Return to Project



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development